News
Abnormal ocular staining scores showed a substantial number of dry eye patients with keratoconjunctivitis sicca that was distinct from Sjögren's syndrome. The new method of assessing ...
WASHINGTON — A nanomicellar formulation of cyclosporine A was well tolerated with a low rate of ocular adverse events or instillation site pain, according to a study presented here. Luchs reported the ...
Background The ocular surface changes of keratoconjunctivitis sicca (KCS) could be the result of the effect of an altered tear film on the epithelial environment. Purpose To evaluate the possibility ...
New York, March 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Keratoconjunctivitis Sicca (Dry Eye) Clinical Trial Analysis by Trial Phase, Trial Status, Trial ...
NEW YORK, Oct. 11, 2017 /PRNewswire/ -- SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2017, ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Keratoconjunctivitis Sicca (Dry Eye) - Pipeline Review, H1 2017" report to their offering. Keratoconjunctivitis Sicca ...
DUBLIN--(BUSINESS WIRE)--The "Keratoconjunctivitis Sicca (Dry Eye) - Global Clinical Trials Review, 2022" clinical trials has been added to ResearchAndMarkets.com's offering. Keratoconjunctivitis ...
DUBLIN--(BUSINESS WIRE)--The "Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. This report provides an ...
DUBLIN--(BUSINESS WIRE)--The "Keratoconjunctivitis Sicca (Dry Eye) - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. Keratoconjunctivitis Sicca (Dry Eye) ...
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Keratoconjunctivitis Sicca (Dry Eye) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results